Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
CD34+细胞上CD25抗原的表达是接受阿扎胞苷治疗的晚期MDS患者预后的独立预测因子。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2014.9
Miltiades, P; Lamprianidou, E; Vassilakopoulos, T P; Papageorgiou, S G; Galanopoulos, A G; Vakalopoulou, S; Garypidou, V; Papaioannou, M; Hadjiharissi, E; Pappa, V; Papadaki, H A; Spanoudakis, E; Tsatalas, K; Kotsianidis, I
